MYC and cancer: c-Myc is an oncogenic transcription factor that can increase the expression of GLS via the repression of specific microRNAs (miR-23a and miR-23b) and consequently stimulates glutamine metabolism in many c-Myc-driven cancers (38), which typically show marked glutamine dependence (52, 53).